These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

176 related items for PubMed ID: 11911400

  • 1. CD105 (endoglin) expression on hematopoietic stem/progenitor cells.
    Pierelli L, Bonanno G, Rutella S, Marone M, Scambia G, Leone G.
    Leuk Lymphoma; 2001; 42(6):1195-206. PubMed ID: 11911400
    [Abstract] [Full Text] [Related]

  • 2. Neutralization of autocrine transforming growth factor-beta in human cord blood CD34(+)CD38(-)Lin(-) cells promotes stem-cell-factor-mediated erythropoietin-independent early erythroid progenitor development and reduces terminal differentiation.
    Akel S, Petrow-Sadowski C, Laughlin MJ, Ruscetti FW.
    Stem Cells; 2003; 21(5):557-67. PubMed ID: 12968110
    [Abstract] [Full Text] [Related]

  • 3. TGF-{beta} signaling of human T cells is modulated by the ancillary TGF-{beta} receptor endoglin.
    Schmidt-Weber CB, Letarte M, Kunzmann S, Rückert B, Bernabéu C, Blaser K.
    Int Immunol; 2005 Jul; 17(7):921-30. PubMed ID: 15967783
    [Abstract] [Full Text] [Related]

  • 4. Expression and function of CD105 during the onset of hematopoiesis from Flk1(+) precursors.
    Cho SK, Bourdeau A, Letarte M, Zúñiga-Pflücker JC.
    Blood; 2001 Dec 15; 98(13):3635-42. PubMed ID: 11739167
    [Abstract] [Full Text] [Related]

  • 5. GATA transcription in a small rhodamine 123(low)CD34(+) subpopulation of a peripheral blood-derived CD34(-)CD105(+) mesenchymal cell line.
    Conrad C, Gottgens B, Kinston S, Ellwart J, Huss R.
    Exp Hematol; 2002 Aug 15; 30(8):887-95. PubMed ID: 12160840
    [Abstract] [Full Text] [Related]

  • 6. Differential effects of the hematopoietic inhibitors MIP-1 alpha, TGF-beta, and TNF-alpha on cytokine-induced proliferation of subpopulations of CD34+ cells purified from cord blood and fetal liver.
    Mayani H, Little MT, Dragowska W, Thornbury G, Lansdorp PM.
    Exp Hematol; 1995 May 15; 23(5):422-7. PubMed ID: 7536684
    [Abstract] [Full Text] [Related]

  • 7. Endoglin is a component of the transforming growth factor (TGF)-beta receptor complex of human pre-B leukemic cells.
    Zhang H, Shaw AR, Mak A, Letarte M.
    J Immunol; 1996 Jan 15; 156(2):564-73. PubMed ID: 8543807
    [Abstract] [Full Text] [Related]

  • 8. Control of hematopoietic stem/progenitor cell fate by transforming growth factor-beta.
    Fortunel NO, Hatzfeld JA, Monier MN, Hatzfeld A.
    Oncol Res; 2003 Jan 15; 13(6-10):445-53. PubMed ID: 12725536
    [Abstract] [Full Text] [Related]

  • 9. Expression and structural features of endoglin (CD105), a transforming growth factor beta1 and beta3 binding protein, in human melanoma.
    Altomonte M, Montagner R, Fonsatti E, Colizzi F, Cattarossi I, Brasoveanu LI, Nicotra MR, Cattelan A, Natali PG, Maio M.
    Br J Cancer; 1996 Nov 15; 74(10):1586-91. PubMed ID: 8932339
    [Abstract] [Full Text] [Related]

  • 10. Abnormal expression of Endoglin and its receptor complex (TGF-β1 and TGF-β receptor II) as early angiogenic switch indicator in premalignant lesions of the colon mucosa.
    Bellone G, Gramigni C, Vizio B, Mauri FA, Prati A, Solerio D, Dughera L, Ruffini E, Gasparri G, Camandona M.
    Int J Oncol; 2010 Nov 15; 37(5):1153-65. PubMed ID: 20878063
    [Abstract] [Full Text] [Related]

  • 11. Release from quiescence of primitive human hematopoietic stem/progenitor cells by blocking their cell-surface TGF-beta type II receptor in a short-term in vitro assay.
    Fortunel N, Hatzfeld J, Kisselev S, Monier MN, Ducos K, Cardoso A, Batard P, Hatzfeld A.
    Stem Cells; 2000 Nov 15; 18(2):102-11. PubMed ID: 10742382
    [Abstract] [Full Text] [Related]

  • 12. Functional, phenotypic and molecular characterization of cytokine low-responding circulating CD34+ haemopoietic progenitors.
    Pierelli L, Scambia G, Fattorossi A, Bonanno G, Battaglia A, Rumi C, Marone M, Mozzetti S, Rutella S, Menichella G, Romeo V, Mancuso S, Leone G.
    Br J Haematol; 1998 Sep 15; 102(5):1139-50. PubMed ID: 9753035
    [Abstract] [Full Text] [Related]

  • 13. Endoglin is an accessory protein that interacts with the signaling receptor complex of multiple members of the transforming growth factor-beta superfamily.
    Barbara NP, Wrana JL, Letarte M.
    J Biol Chem; 1999 Jan 08; 274(2):584-94. PubMed ID: 9872992
    [Abstract] [Full Text] [Related]

  • 14. Transforming growth factor-beta regulates the cell cycle status of interleukin-3 (IL-3) plus IL-1, stem cell factor, or IL-6 stimulated CD34+ human hematopoietic progenitor cells through different cell kinetic mechanisms depending on the applied stimulus.
    Lardon F, Snoeck HW, Nijs G, Lenjou M, Peetermans ME, Rodrigus I, Berneman ZN, Van Bockstaele DR.
    Exp Hematol; 1994 Aug 08; 22(9):903-9. PubMed ID: 7520393
    [Abstract] [Full Text] [Related]

  • 15. Differential expression of transforming growth factor-beta, basic fibroblast growth factor, and their receptors in CD34+ hematopoietic progenitor cells from patients with myelofibrosis and myeloid metaplasia.
    Le Bousse-Kerdilès MC, Chevillard S, Charpentier A, Romquin N, Clay D, Smadja-Joffe F, Praloran V, Dupriez B, Demory JL, Jasmin C, Martyré MC.
    Blood; 1996 Dec 15; 88(12):4534-46. PubMed ID: 8977245
    [Abstract] [Full Text] [Related]

  • 16. Transforming growth factor-beta1 transcriptionally activates CD34 and prevents induced differentiation of TF-1 cells in the absence of any cell-cycle effects.
    Marone M, Scambia G, Bonanno G, Rutella S, de Ritis D, Guidi F, Leone G, Pierelli L.
    Leukemia; 2002 Jan 15; 16(1):94-105. PubMed ID: 11840268
    [Abstract] [Full Text] [Related]

  • 17. TNF alpha down-regulates CD105 expression in vascular endothelial cells: a comparative study with TGF beta 1.
    Li C, Guo B, Ding S, Rius C, Langa C, Kumar P, Bernabeu C, Kumar S.
    Anticancer Res; 2003 Jan 15; 23(2B):1189-96. PubMed ID: 12820370
    [Abstract] [Full Text] [Related]

  • 18. Transforming growth factor-beta1 causes transcriptional activation of CD34 and preserves haematopoietic stem/progenitor cell activity.
    Pierelli L, Marone M, Bonanno G, Rutella S, de Ritis D, Mancuso S, Leone G, Scambia G.
    Br J Haematol; 2002 Aug 15; 118(2):627-37. PubMed ID: 12139758
    [Abstract] [Full Text] [Related]

  • 19. Role of endoglin in cellular responses to transforming growth factor-beta. A comparative study with betaglycan.
    Letamendía A, Lastres P, Botella LM, Raab U, Langa C, Velasco B, Attisano L, Bernabeu C.
    J Biol Chem; 1998 Dec 04; 273(49):33011-9. PubMed ID: 9830054
    [Abstract] [Full Text] [Related]

  • 20. Immunohistochemical evaluation of the microvascular density through the expression of TGF-beta (CD 105/endoglin) and CD 34 receptors and expression of the vascular endothelial growth factor (VEGF) in oligodendrogliomas.
    Netto GC, Bleil CB, Hilbig A, Coutinho LM.
    Neuropathology; 2008 Feb 04; 28(1):17-23. PubMed ID: 18181830
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.